The next generation of energy storage has been developed using graphene to create supercapacitors that could be used for renewable energy storage.
By Kris Walker
16 Oct 2013
A mix of graphene and polyurethane could be the key to a boost in effiency for vehicles running on compressed natural gas (CNG) , and improve the shelf life of bottled beer and fizzy drinks.
By Will Soutter
11 Oct 2013
Nanoscale coatings of the 2D material hexagonal boron nitride (h-BN) have been shown to prevent materials from oxidizing under high temperature conditions, in a news study from Rice University.
By Will Soutter
9 Oct 2013
A new fuel cell catalyst made from gelatin has been created at Birmingham University. The material could replace the much more expensive platinum in fuel cells for vehicles and small-scale electricity generation.
By Will Soutter
4 Oct 2013
Phenom-World recently launched the new generation of their flagship Phenom benchtop SEMs. AZoNano spoke to Phenom-World CEO Emile Asselbergs about the new Phenom, and the company's heritage and philosophy.
Engineers at Stanford have created the first working carbon nanotube computer - validating the technology as a potential replacement for silicon semiconductors in electronics.
By Will Soutter
26 Sep 2013
Novel drug delivery is one of the most-researched areas of nanomedicine - now MIT researchers are advancing the field even further with a nanoparticle aerosol spray that could be used to deliver vaccines or cancer treatments via an inhalable spray.
By Will Soutter
25 Sep 2013
This article talks about the dynamic characterization of nanomechanical force actuators under a vacuum.
Researchers at the University of Sydney have developed a new nanostructured material which uses "raspberry particles" to trap water droplets on its surface, with potential applications from preventing condensation to rapid, portable medical tests.
By Will Soutter
20 Sep 2013
Scientists from the nanotech research collaborative Nanoprobes have developed a treatment for cancer using magnetic nanoparticles, which has cured 80% of mice in initial trials.